Beauty Farm Medical and Health Industry Inc. repurchased 9,500 ordinary shares on 08 September 2026, according to its Next Day Disclosure Return filed with the Hong Kong Stock Exchange.

The on-exchange transaction was completed at prices ranging between HKD 17.96 and HKD 17.98, producing a volume-weighted average repurchase price of HKD 17.97 per share and an aggregate consideration of HKD 0.17 million.

Following the buyback, the company’s issued share capital (excluding treasury shares) declined by 0.0038 % to 247.90 million shares, while the treasury share balance rose to 3.70 million. Total issued shares remained unchanged at 251.59 million.

The purchase was made under the general mandate approved on 26 June 2026, which authorises Beauty Farm to repurchase up to 24.85 million shares. Including the latest transaction, the company has repurchased 623,500 shares under this mandate, representing 0.25 % of the issued share count at the time the resolution was passed.

Under Main Board Rule 10.06, Beauty Farm is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares until 08 October 2026.